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Abstract. Numerous studies have stated that humans need 
to utilise full sun radiation, at certain times of the day, to 
assist the body in synthesising the required levels of 
vitamin D3. Current Australian guidelines suggest 
exposure to approximately 1/6 to 1/3 of a minimum 
erythemal dose (MED), depending on age, would be 
appropriate to provide adequate vitamin D levels. In the 
light of the considerable body of evidence regarding the 
harm done by excessive UV exposure and the public 
awareness of skin cancer, new public health programs are 
needed in order to optimize human solar UV exposure. 
Utilizing scattered solar UV radiation to obtain beneficial 
amounts of UV, while at the same time reducing personal 
overexposure to harmful UV radiation may prove to be 
absolutely necessary for an improvement in public health. 
Solar UV and Vitamin D 
The health effects of solar UV radiation vary significantly, 
from assisting calcium absorption in humans due to the 
initiation of the synthesis of vitamin D3 to the severe 
degradation of body tissue. The good effects are relatively 
few, but they are essential to a persons well being. It is 
well known that exposure to small amounts of UVB 
radiation are beneficial for the human body and important 
in the production of vitamin D3, whereas excessive 
exposure to UVB and UVA is known to cause skin cancer, 
DNA damage, immune suppression, erythema and 
sun-related eye disorders (Glerup et al, 2000; Terenetskaya, 
2000; Sliney, 1994). Epidemiological data and animal 
studies also indicate that low blood serum vitamin D3 is 
linked to breast cancer, prostate cancer, colorectal cancer, 
non-Hodgkin’s lymphoma, multiple sclerosis, diabetes, 
bacterial infections, inflammatory bowel disease, elevated 
cholesterol and rheumatoid arthritis (Holick, 2004; 
Garland et al, 2006). It has been estimated that the number 
of premature deaths from cancer due to insufficient 
vitamin D in the USA is 50,000 to 60,000 annually and 
19,000 to 25,000 in the UK annually (Grant et al., 2005). 
The associated cost in the USA for 2004 due to insufficient 
vitamin D3 has been estimated at $40 to $56 billion (Grant 
et al., 2005). Vitamin D3 is also important for the 
prevention of rickets in children, osteoporosis, 
osteomalacia, and falls and fractures in the elderly (Holick, 
2004). Total direct costs related to fall injuries in the USA 
for people 65 and older in 2000 was more than $19 billion 
(Stevens et al., 2006) and is expected to rise to 
approximately $43.8 billion by 2020 (Englander et al., 
1996). 
It is estimated that approximately 90-95% of our vitamin 
D3 requirement comes from exposure to the sun (Holick, 
2004; 1998). The synthesis of vitamin D3 is initiated 
through exposure of human skin to UVB radiation. The 
longer wavelength UVA radiation plays no part in the 
synthesis of vitamin D3 in humans. In comparison, 
research by Agar et al. (2004) has shown that UVA plays a 
significant role in human skin carcinogenesis. Therefore, 
reducing exposure to UVA while still receiving sufficient 
amounts of the UVB wavelengths required to produce 
recommended vitamin D3 levels is essential. Although, 
over exposure to these UVB wavelengths are known to 
cause skin damage, vitamin D3 synthesis occurs at doses 
far below those needed for damage to arise (Webb, 1993). 
Recently, a position statement was approved by the 
Working Group of the Australian and New Zealand Bone 
and Mineral Society, Endocrine Society, Osteoporosis 
Australia, Australian College of Dermatologists and the 
Cancer Council Australia recommending five minutes UV 
exposure either side of the peak UV periods on most days 
of the week in summer and 2-3 hours solar UV exposure 
over a week in winter (PS, 2006). 
Shade and Vitamin D.  
Studies on the levels of UV observed in the shade of 
different shade environments (e.g. Turnbull & Parisi, 2003; 
Turnbull et al, 2005; 2003; Parisi et al, 2001) have shown 
that the ratios of UVB to UVA in the shade are 
significantly different to that in full sun (Figure 1). The 
ratio of UVB to UVA is higher in the shade than in the sun. 
These differences are due to atmospheric scattering, which 
causes greater scattering at the shorter UVB wavelengths 
and reduced scattering at the longer wavelength UVA. 
Therefore, the shade holds the effective wavelengths 
needed for vitamin D3 production in the body, but not the 
high levels of UVA experienced in full sun. Spectral 
measurements showed that, for a solar zenith angle of 40o 
(latitude of 27.6oS), the UVA (315-400 nm) in the scattered 
component of the solar UV is reduced by approximately 
62% compared to the UVA in the global UV, whereas 
vitamin D3 effective wavelengths are only reduced by 
approximately 43%. 
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Figure 1. Scattered, global and ratio of spectral UV irradiances 
taken on 17 August 2005 at approximately 11:10 EST. 
Current Australian guidelines suggest exposure to 
approximately 1/6 to 1/3 of a MED (minimum erythemal 
dose), depending on age, would be appropriate to provide 
adequate vitamin D3 levels (Samanek et al, 2006; CDHAA, 
2006). Researchers at the University of Southern 
Queensland measured scattered and global erythemal UV 
at five minute intervals over a twelve month period for a 
solar zenith angle (SZA) range of 4o to 80o at a latitude of 
27.6oS. The times required for exposure to 1/6 MED from 
scattered erythemal UV on a horizontal plane for SZA 
greater than 4o are shown in Figure 2. For scattered UV 
exposures of 1/6 and 1/3 MED, solar zenith angles smaller 
than 60o and 50o respectively can be utilised for exposure 
times of less than 10 minutes.  
Figure 2. The times required for an exposure of 1/6 MED due to 
scattered UV as a function of SZA for all sky conditions during 
2003. 
The values provided in this paper are for pale skin and for 
a sky view that is not blocked, apart from the blocking of 
the solar disc. For larger structures the amount of sky view 
will be reduced due to the structural components of the 
shade structure, causing the exposure times required for 
the respective exposures due to the scattered UV to be 
slightly longer.  
The importance of this research is that it provides a basis 
for public health campaigns aimed at reducing the 
incidence of vitamin D3 deficiency and its attendant 
disorders, as well as reducing over exposure to harmful 
solar UV radiation. Utilizing scattered solar UV radiation 
to obtain beneficial amounts of UV, while at the same time 
reducing personal overexposure to harmful UV radiation 
may prove to be absolutely necessary for an improvement 
in public health.  
The findings in this paper may have significant 
ramifications for future public health policy regarding sun 
exposure, which is currently being debated in many 
countries (Diffey, 2006; Gillie, 2006). Also, the findings of 
this research may prove useful to those that work from 9 
am to 5 pm, where solar UV exposure at noon or during a 
lunch break may be the only option for the necessary UV 
exposures to initiate the synthesis of vitamin D3. Therefore, 
advice to stay out of the sun in the middle of the day, 
which is best for vitamin D3 synthesis in the skin, can be 
adjusted to advocate the possible use of appropriate shade 
environments.  
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